- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
H4B.2: 11 residues within 4Å:- Chain A: S.38, M.40, R.300, V.381, W.382
- Chain B: W.380, F.395, H.396, Q.397, E.398
- Ligands: HEM.1
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.300, A:V.381, A:W.382
- pi-Stacking: A:W.382, A:W.382
- pi-Cation interactions: A:W.382
- Hydrophobic interactions: B:E.398
H4B.8: 13 residues within 4Å:- Chain A: W.10, W.380, F.395, H.396, Q.397, E.398
- Chain B: S.38, M.40, R.300, V.381, W.382
- Ligands: HEM.7, 01.9
10 PLIP interactions:1 interactions with chain A, 9 interactions with chain B- Hydrophobic interactions: A:E.398
- Hydrogen bonds: B:R.300, B:V.381, B:W.382
- Water bridges: B:R.300, B:R.300
- pi-Stacking: B:W.382, B:W.382
- pi-Cation interactions: B:W.382, B:W.382
- 2 x 01: 6-({2,3-difluoro-5-[2-(4-fluoropiperidin-1-yl)ethyl]phenoxy}methyl)-4-methylpyridin-2-amine
01.3: 15 residues within 4Å:- Chain A: M.40, Q.182, R.185, Y.266, P.269, A.270, V.271, F.288, S.289, G.290, W.291, Y.292, M.293, E.296
- Ligands: HEM.1
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:P.269, A:V.271, A:F.288
- Hydrogen bonds: A:M.293, A:E.296
- Halogen bonds: A:Y.266
01.9: 14 residues within 4Å:- Chain B: Q.182, R.185, Y.266, P.269, A.270, V.271, F.288, W.291, Y.292, M.293, E.296, W.382
- Ligands: HEM.7, H4B.8
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:V.271, B:F.288, B:W.382
- Hydrogen bonds: B:M.293, B:E.296
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 4 residues within 4Å:- Chain A: L.20, K.23, Q.68, R.373
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.68, A:R.373
GOL.5: 6 residues within 4Å:- Chain A: I.106, K.110, S.126, L.128, Q.129, V.130
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.110, A:L.128, A:V.130, A:V.130
GOL.10: 6 residues within 4Å:- Chain B: I.106, K.110, S.126, L.128, Q.129, V.130
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.110, B:L.128
GOL.11: 4 residues within 4Å:- Chain B: Q.68, R.373, L.404, T.405
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Q.68, B:R.373
- Water bridges: B:K.23, B:T.405
- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ansari, A. et al., Highly potent, selective, and membrane permeable ether linked 2-aminopyridine-based human neuronal nitric oxide synthase inhibitors. To Be Published
- Release Date
- 2025-09-10
- Peptides
- Nitric oxide synthase, brain: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
SMTL ID : 9q4n.2 (1 other biounit)
Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain bound with 6-((2,3-difluoro-5-(2-(4-fluoropiperidin-1-yl)ethyl)phenoxy)methyl)-4-methylpyridin-2-amine
Nitric oxide synthase, brain
Related Entries With Identical Sequence
7ts1.1 | 7ts1.2 | 7ts2.1 | 7ts2.2 | 7ts3.1 | 7ts3.2 | 7ts4.1 | 7ts4.2 | 7ts5.1 | 7ts5.2 | 7ts6.1 | 7ts6.2 | 7ts7.1 | 7ts7.2 | 7ts8.1 | 7ts8.2 | 7uam.1 | 7uam.2 | 7us7.1 | 7us7.2 | 7us8.1 | 7us8.2 | 8fgh.1 | 8fgh.2 | 8fgj.1 | 8fgj.2 | 8fgk.1 | 8fgk.2 | 8ufp.1 | 9c1y.1 more...less...9c1y.2 | 9cvs.1 | 9cvs.2 | 9cvu.1 | 9cvu.2 | 9cvv.1 | 9cvv.2 | 9cvw.1 | 9cvw.2 | 9cvx.1 | 9cvx.2 | 9cvy.1 | 9cvy.2 | 9cvz.1 | 9cvz.2 | 9cw0.1 | 9cw0.2 | 9cw1.1 | 9cw1.2 | 9cw3.1 | 9cw3.2 | 9q4g.1 | 9q4g.2 | 9q4h.1 | 9q4h.2 | 9q4i.1 | 9q4i.2 | 9q4j.1 | 9q4j.2 | 9q4k.1 | 9q4k.2 | 9q4m.1 | 9q4m.2 | 9q4n.1 | 9q4o.1 | 9q4o.2